Dipeptidyl saccharides as host resistance enhancers in AIDS-immu

Details Dipeptidyl saccharides as host resistance enhancers in AIDS-immu Dipeptidyl saccharides as host resistance enhancers in AIDS-immu

1987-10-05

1989-09-12

Kight, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 9, 514 11, 514 21, 514 42, 514 44, 514 46, 514 50, 514 75, 514 78, 514357, A61K 3702, A61K 3900

Patent

active

048660353

ABSTRACT:
Disclosed are specific dipeptidyl saccharide derivatives which alone, or in combination with an anti-AIDS drug, e.g. azidothymidine, provide protection against opportunistic infection in human individuals whose resistance to infection has been specifically suppressed by an AIDS-related (HIV) virus, as well as help to suppress the AIDS-related infection itself.

REFERENCES:
patent: 4368190 (1983-01-01), Shen et al.
Dagani, "Efforts Intensify to Develop Drugs, Vaccines that Combat AIDS", C & E News, Dec. 8, 1986, pp. 7-14.

Affiliated with

Also associated with

Rating

Dipeptidyl saccharides as host resistance enhancers in AIDS-immu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dipeptidyl saccharides as host resistance enhancers in AIDS-immu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl saccharides as host resistance enhancers in AIDS-immu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-916272